Skip to content

BioLife Solutions BLFS Repayments Of Secured Debt

Repayments Of Secured Debt at other companies

STERIS logo
STERISSTE

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B-14.0%
Enterprise value$1.24B-11.2%
P/S12.5×-6.0×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfSecuredDebt.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's repayments of secured debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's repayments of secured debt?
BioLife Solutions (BLFS) reported repayments of secured debt of $2.5M in Q1 2026.
How has BioLife Solutions's repayments of secured debt changed year-over-year?
BioLife Solutions's repayments of secured debt decreased by 0.0% year-over-year, from $2.5M to $2.5M.
What does repayments of secured debt mean?
Cash outflows used to pay down the principal balance of debt obligations backed by collateral. This reflects the company's commitment to deleveraging its balance sheet and reducing interest-bearing liabilities.